About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Los Angeles | 72 Studies

Clinical Trials Pancreatic CancerLos Angeles

Pancreatic Cancer Clinical Trials in Los Angeles

Find 72 clinical trials for pancreatic cancer near Los Angeles, California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 72 trials

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others CompletedPediatric Longitudinal Cohort Study of Chronic PancreatitisThe investigators will enroll a total of 628 patients under 18 years of age with ARP or CP.NCT03672422·Beverly Hills, California and 21 others

Pancreatic Cancer Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

CompletedDNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.NCT04825834·Homewood, Alabama and 56 others

CompletedA Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid TumorsThe study consists of 2 parts.NCT04247126·Gilbert, Arizona and 15 others

CompletedRadiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003591·Birmingham, Alabama and 233 others

CompletedSelumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R MutationsThis phase II trial studies how well selumetinib sulfate works in treating patients with pancreatic cancer with Kirsten rat sarcoma (KRAS) G12R mutations that has spread from…NCT03040986·Los Angeles, California and 8 others

CompletedA Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid TumorsStudy CP-MGC018-02 is a study of vobramitamab duocarmazine (MGC018) in combination with lorigerlimab (MGD019).NCT05293496·Los Angeles, California and 9 others

CompletedFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerThis randomized phase II trial studies how well modified irinotecan hydrochloride, leucovorin calcium, fluorouracil (FOLFIRI) and veliparib as a second line of therapy work…NCT02890355·Mobile, Alabama and 782 others

CompletedA Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor PatientsThis is an open label, dose finding, phase Ib clinical trial to determine the maximum tolerated dose (MTD) and /or recommended phase II dose (RP2D) and schedule for the PI3K…NCT01155453·Los Angeles, California and 6 others

Terminated89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsA prospective, open-label, phase 2 study to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT imaging in patients with…NCT05563272·Los Angeles, California and 9 others

Active not recruitingTesting the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic CancerThis phase I trial studies the side effects and best dose of anetumab ravtansine when given together with nivolumab, ipilimumab and gemcitabine hydrochloride in treating patients…NCT03816358·Birmingham, Alabama and 44 others

RecruitingA Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesRSC-101 is a Phase 1a/1b clinical trial of RSC-1255 in adult study participants with advanced solid tumor malignancies who are intolerant of existing therapies known to provide…NCT04678648·Los Angeles, California and 2 others

CompletedBMS-247550 in Treating Patients With Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00016965·Mobile, Alabama and 94 others

RecruitingStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.NCT07252232·Phoenix, Arizona and 77 others

CompletedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well fluorouracil, irinotecan hydrochloride, and oxaliplatin (combination chemotherapy) works and compares to gemcitabine hydrochloride…NCT02562716·Birmingham, Alabama and 806 others

CompletedTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsThis randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors.NCT01824875·Anaheim, California and 322 others

CompletedA Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsThis is a Phase 1 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus a mixture of…NCT04853017·Duarte, California and 9 others

CompletedEverolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well everolimus and octreotide acetate with or without bevacizumab works in treating patients with pancreatic neuroendocrine tumors that…NCT01229943·Mobile, Alabama and 393 others

CompletedPhase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerThe purpose of the study is to determine whether positron emission tomography (PET), using the new imaging drug \[124 I\] PSCA-Minibody can be used for imaging prostate…NCT02092948·Los Angeles, California

PreviousPage 2 of 4Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia